Search research articles
Contact Us
Filters
Showing results (101-110 of 224) with videos related to
Page
of 23
Sort By:
Melanoma Research
|
October 22, 2016
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients
Nitin Chakravarti, Doina Ivan, Van A Trinh, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
October 30, 2018
Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma
Oded Sagiv, Diana Bell, Yunxia Guo, et al.
Journal of Cutaneous Pathology
|
April 20, 2018
Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall
Maya Farah, Priyadharsini Nagarajan, Carlos A Torres-Cabala, et al.
Oncotarget
|
February 1, 2018
Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
Shujing Liu, Michael T Tetzlaff, Tao Wang, et al.
Human Pathology
|
March 31, 2018
Intratumoral and peritumoral lymphovascular invasion detected by D2-40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma
Rami N Al-Rohil, Denái R Milton, Priyadharsini Nagarajan, et al.
The American Journal of Dermatopathology
|
January 31, 2017
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features
Michael T Tetzlaff, Priyadharsini Nagarajan, Susan Chon, et al.
The American Journal of Dermatopathology
|
June 21, 2014
Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy
Jonathan L Curry, Michael T Tetzlaff, Kimberly Nicholson, et al.
International Journal of Dermatology
|
November 21, 2017
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade
Shakuntala H Mauzo, Michael T Tetzlaff, Kelly Nelson, et al.
JAMA Ophthalmology
|
July 24, 2015
Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs
Michael T Tetzlaff, Jonathan L Curry, Vivian Yin, et al.
Journal of Cutaneous Pathology
|
August 13, 2016
Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: report of a case
Hedieh H Honarpisheh, Jonathan L Curry, Kristen Richards, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 224) with videos related to
Sort By:
Page
of 23
Melanoma Research
|
October 22, 2016
High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients
Nitin Chakravarti, Doina Ivan, Van A Trinh, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
October 30, 2018
Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma
Oded Sagiv, Diana Bell, Yunxia Guo, et al.
Journal of Cutaneous Pathology
|
April 20, 2018
Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall
Maya Farah, Priyadharsini Nagarajan, Carlos A Torres-Cabala, et al.
Oncotarget
|
February 1, 2018
Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
Shujing Liu, Michael T Tetzlaff, Tao Wang, et al.
Human Pathology
|
March 31, 2018
Intratumoral and peritumoral lymphovascular invasion detected by D2-40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma
Rami N Al-Rohil, Denái R Milton, Priyadharsini Nagarajan, et al.
The American Journal of Dermatopathology
|
January 31, 2017
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features
Michael T Tetzlaff, Priyadharsini Nagarajan, Susan Chon, et al.
The American Journal of Dermatopathology
|
June 21, 2014
Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy
Jonathan L Curry, Michael T Tetzlaff, Kimberly Nicholson, et al.
International Journal of Dermatology
|
November 21, 2017
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade
Shakuntala H Mauzo, Michael T Tetzlaff, Kelly Nelson, et al.
JAMA Ophthalmology
|
July 24, 2015
Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs
Michael T Tetzlaff, Jonathan L Curry, Vivian Yin, et al.
Journal of Cutaneous Pathology
|
August 13, 2016
Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: report of a case
Hedieh H Honarpisheh, Jonathan L Curry, Kristen Richards, et al.
Page
of 23